Skip to content

Five Point Initiative: A Bundled Implementation Strategy to Address the HIV Epidemic in Black Communities

Five Point Initiative: A Cluster Randomized Trial of a Bundled Implementation Strategy to Address the HIV Epidemic in Black Communities

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06062342
Acronym
FPI
Enrollment
20400
Registered
2023-10-02
Start date
2024-02-02
Completion date
2029-06-30
Last updated
2026-08-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hiv

Keywords

HIV prevention, HIV testing, PrEP, Implementation Science

Brief summary

The purpose of this study is to assess the effectiveness of the FPI bundled implementation strategy in increasing HIV testing, Pre-exposure prophylaxis (PrEP) linkage (e.g., prescription) and knowledge, and condom use/access.

Interventions

BEHAVIORALFPI

The FPI intervention will be conducted twice per month (across 21 months) in a zip code, and each event will last approximately 4-5 hours. At the event, participants will receive HIV testing, PrEP linkage (e.g., prescription) and knowledge, and condom and use/access.

Sponsors

University of Miami
Lead SponsorOTHER
National Institute of Mental Health (NIMH)
CollaboratorNIH

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
PREVENTION
Masking
NONE

Intervention model description

This is a stepped wedge trial and all zip codes cross over from pre-assessment period (control) to active intervention. The time/order in which zip codes enter the stepped wedge is the unity of randomization.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Any individual present during the community events at the "five points" (barbershop, hair/beauty salon store or salon, corner store/grocery/neighborhood restaurant, laundromats, car service provider \[e.g. gas station, mechanic, car wash\]) in predominantly Black communities in Miami where HIV prevalence is high. * Pre- and Post-assessment: Individuals are only eligible to complete the survey one time during the Pre-Intervention and during the Post-Intervention phases. * Intervention: Individuals are only eligible to participate in the Intervention phase of this study once every 6 months.

Exclusion criteria

* Individuals who are unable to completely and fully understand the informed (verbal) consent process and the study procedures. * Individuals who have previously completed the survey during the Pre-Intervention and Post-Intervention phases. * Individuals who have participated in the Intervention phase of this study within less than 6 months.

Design outcomes

Primary

MeasureTime frameDescription
Change in number of residents with recent HIV testingUp to 23 monthsWill be reported as proportion of residents with recent (within 12 months) HIV testing as measured by Five Point Initiative - Community Survey
Change in number of residents with PrEP prescriptionUp to 23 monthsWill be reported as proportion of residents with PrEP prescription as measured by Five Point Initiative - Community Survey
Change in PrEP knowledge as measured by Five Point Initiative - Community SurveyBaseline and up to 23 monthsWill be reported as the proportion of residents that indicated 'Yes' on the survey.

Secondary

MeasureTime frameDescription
Proportion of residents with recent HIV testing by health organizationsUp to 23 monthsProportion of residents with recent (within 12 months) HIV testing by each of the participating health organizations.
Change in condom use as measured by Five Point Initiative - Community SurveyBaseline and up to 23 monthsWill be reported as the proportion of residents that indicated 'No' on the survey
Number of residents with PrEP prescription by health organizationsUp to 23 monthsNumber of residents with PrEP prescription by each of the participating health organizations.
Change in condom access as measured by Five Point Initiative - Community SurveyBaseline and up to 23 monthsWill be reported as the proportion of residents that indicated 'Yes' on the survey

Countries

United States

Contacts

CONTACTSannisha Dale, PhD
sdale@med.miami.edu(305) 243-6714
CONTACTSHINE Research Program
shineresearch@miami.edu
PRINCIPAL_INVESTIGATORSannisha Dale, PhD

University of Miami

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 29, 2026